In the present study, we identified three pediatric cases of acute myeloid leukemia (AML) with features of well-differentiated DCs.
We performed a morphological, immunological and molecular characterization of these cases using well-established methodologies. Detailed information regarding Materials and methods are reported in Supplementary Materials and methods.
Demographic and clinical features of all three patients are listed in Table 1 . They were admitted in three different children's hospitals in Italy (Catania for case 1; Padova for case 2; Catanzaro for case 3). They presented with fever, pallor, abdominal and joint pain, cervical adenopathy and mild hepatosplenomegaly. In all three cases, the white blood cell count was normal. There was no involvement of the central nervous system. Morphologic evaluation of the bone marrow aspirates was similar in the three cases. The marrows were completely replaced with large blasts in a percentage of 85, 80 In bold are shown the antigens used for specifically defining the dendritic cell nature of this form of leukemia.
Letters to the Editor and 85% for cases 1, 2 and 3, respectively. The blasts were characterized by irregular nuclei, slightly basophilic cytoplasm and prominent cytoplasmic projections. There were no cytoplasmatic granules and no evidence of phagocytosis (Figure 1a c). Myeloperoxidase (MPO) and alpha naphthyl acetate esterase (aNAE) reactions were negative (Figure 1d ). Additional morphological features are shown in Supplementary Figure 1A (for case 1), 1B (case 2) and 1C (case 3). We provided several images of blasts in order to demonstrate the DC nature of this form of leukemia. Table 1 lists immunological, cytogenetic and molecular findings regarding these cases. The leukemic blasts in all three cases showed CD11c and CD83 expression, which are very specific surface markers of DC lineage. 2, 6 According to immunological gate on CD45 and light scattering, almost all the blasts expressed CD83 in cases 2 and 3, respectively. In case 1, only 55% of the blasts presented with a high expression of CD83. These findings are consistent with morphological data. At presentation, CD83 expression in our cases was from two to 10 times higher than that of DCs obtained in vitro from normal monocytes.
2 A high expression of CD86 and CD116 antigens was also found, consistently with dendritic myeloid cells differentiation.
2,3
The morphology and immunophenotype suggested an acute differentiated DC leukemia. All three patients achieved remission after intensive chemotherapy remaining in first remission (duration 40-70 months) after different hematopoietic stem cell transplantation procedures (Table 1 ). All three cases were characterized by MLL gene rearrangements.
These cases could not be classified on the basis of either morphologic FAB or WHO criteria. 4, 5 For this reason, the immunophenotype was crucial, showing a high expression of HLA-DR, CD11c, CD83, CD86 and CD116 antigens, which indicated that the leukemias presumably were of a mature DC lineage. 2 Particularly, CD83 is a member of the Ig supergene family found mainly on DCs and it has been reported to be highly specific for defining DCs. 2 In order to confirm this statement of specificity, we retrospectively evaluated CD83 expression in a cohort of more than 100 diagnostic samples derived from children with AML and found no evidence of expression among these cases, including patients with monocytic leukemia (unpublished data).
The expression of CD11c, which is an alfa-X integrin, was considered at a high level of specificity for DC origin, as recently shown by others. 6 CD86 is a member of the B7 family of co-stimulatory molecules that recognizes a surface protein expressed primarily on DCs, monocyte-derived DCs and activated B cells.
2 After GM-CSF, IL-4 and TNF-a stimulation, leukemic cells from variable AML FAB subtypes expressed HLA-DR, CD80, CD83 and CD86, characteristics of mature/activated DCs. 2, 3 Seven acute leukemias of plasmacytoid DC origin have been described, 7 which were characterized by an undifferentiated (CD4 þ /HLA-DR þ /CD45 þ ) phenotype with CD56 positivity and absence of myeloid antigen expression. 7 Although four adult cases of FAB M5b AML characterized by HLA-DR, CD4, CD13, CD33, CD80, CD83, CD86 expression have also been described, 8 expression of CD11c was not mentioned and the clinical presentation was with hyperleukocytosis and skin nodules. There were also no clonal cytogenetic aberrations characterizing these cases. 8 Conversely, all three cases in our study harbored an MLL translocation with a recurrent partner gene of MLL. The in-frame MLL fusion transcripts in the DC leukemias studied here are similar to other MLL fusion transcripts disrupting AF-9 or AF-10 in cases of AML (see Supplementary Figure 2 -text). It is possible that covert cases of acute DC AML may be uncovered in the pediatric population with MLL-rearranged MPO-negative, 5 These two authors contributed equally to this work.
